Federal Register / Vol. 86, No. 181 / Wednesday, September 22, 2021 / Notices 52691 

demonstrated commitment to the SMBP 

Program’s overarching goals and 

objectives: 

• Working to increase behaviors 

women can take to improve their heart 

health; 

• Increasing access to resources and 

information regarding hypertension, 

cardiovascular disease, health risks 

associated with high blood pressure, 

and factors that increase the risk of high 

blood pressure; 

• Increasing knowledge and 

utilization of SMBP activities (also 

referred to as ‘‘self-monitoring’’); 

• Increasing understanding of blood 

pressure needs and understanding of 

blood pressure numbers; 

• Increasing number of women 

collaborating with healthcare providers 

with a focus on self-monitoring blood 

pressure control, with special 

consideration to adapt or modify 

activities to meet the needs of diverse, 

minority, underserved, and hard to 

reach populations; 

• Expanding efforts to reach those 

disproportionately affected by high 

blood pressure, including Black or 

African American women, Latina 

women, Asian/Pacific Islander women, 

American Indian/Alaska Native women, 

women of reproductive age, women in 

rural communities, and women across 

the lifespan, to include those negatively 

affected by comorbidities and social 

determinants of health; 

• Developing partnerships to promote 

SMBP across a variety of sectors, 

including business, community, 

academic, education, faith based, 

government, health care, media, public 

health, and technology; 

• Partnering with national, state, 

tribal, or local volunteer organizations 

to provide education, training, or 

programs regarding health promotion, 

disease prevention, hypertension, 

SMBP, health disparities, health equity, 

and well-being; and/or 

• Including information in their 

public facing materials about programs 

for hypertension, addressing SMBP, 

eliminating disparities, achieving health 

equity, and/or promoting well-being in 

communities. 

Funds: Neither HHS nor OWH will 

provide funds to support SMBP Program 

partners. Applicants, OWH, and SMBP 

Program partners will not be expected to 

contribute funds. 

Application: Organizations may apply 

to be an SMBP Program partner. 

Organizations should submit a letter of 

interest acknowledging their support of 

the SMBP Program’s overarching goals. 

Organizations interested in being SMBP 

Program partners shall identify in their 

letters of interest those activities from 

the list noted above that demonstrate 

commitment to the SMBP Program’s 

overarching goals and objectives and 

indicate how they address or support 

those goals. 

DATES: Letters of interest to become an 

SMBP Program partner should be 

submitted to OWHBPPartner@hhs.gov. 

Letters of interest will be accepted 

starting October 1, 2021 and will be 

reviewed periodically. OWH will 

conduct informational webinars for 

interested applicants. Interested 

organizations may use the following 

links to register for the informational 

webinars: 

• September 24, 2021, at 1 p.m. Eastern 

Time (ET) 

• September 27, 2021, at 1 p.m. Eastern 

Time (ET) 

ADDRESSES: Letters of interest can be 

submitted via email to OWHBPPartner@

hhs.gov. 

FOR FURTHER INFORMATION CONTACT: 

Keiva Nelson, Office on Women’s 

Health, Office of the Assistant Secretary 

for Health, U.S. Department of Health 

and Human Services; 200 Independence 

Avenue SW, 712E, Washington, DC 

20201; Email: OWHBPPartner@hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The HHS Office on 

Women’s Health (OWH) is charged with 

providing expert advice and 

consultation to the Secretary concerning 

scientific, legal, ethical, and policy 

issues related to women’s health. OWH 

establishes short-range and long-range 

goals within the Department and 

coordinates on activities within the 

Department that relate to disease 

prevention, health promotion, service 

delivery, research, and public and 

health care professional education, for 

issues of particular concern to women 

throughout their lifespan. OWH 

monitors the Department’s activities 

regarding women’s health and identifies 

needs regarding the coordination of 

activities. OWH is also responsible for 

facilitating the exchange of information 

through the National Women’s Health 

Information Center. Additionally, OWH 

coordinates efforts to promote women’s 

health programs and policies with the 

private sector. 

Requirements of Interested 

Organizations: OWH invites 

organizations to submit a letter of 

interest to become a SMBP Program 

partner. 

Organizations selected by OWH to be 

SMBP Program partners will sign a 

letter of understanding (LOU) with 

OWH outlining the terms and 

parameters of their support for the 

SMBP Program. Selection as an SMBP 

Program partner does not imply any 

federal endorsement of the collaborating 

organization’s general policies, 

activities, or products. 

Eligibility for Interested 

Organizations: To be eligible to become 

an SMBP Program partner, an 

organization shall: (1) Have a 

demonstrated interest in, understanding 

of, and experience with working to 

promote access to resources and 

information regarding hypertension, 

cardiovascular disease, factors that 

increase the risk of high blood pressure, 

health risks associated with high blood 

pressure, prevention strategies and selfmeasured blood pressure, health 

disparities, and health equity or (2) have 

an organizational or corporate mission 

that is aligned with the SMBP Program’s 

goals; and (3) agree to sign a LOU with 

OWH, which will set forth the details of 

how the organization is supporting the 

goals of the SMBP Program. 

Letter of Interest Requirements: Each 

SMBP Program letter of interest shall 

contain: (1) Organization name, 

location, website, and submitter’s 

contact information; (2) a brief 

description of the organization’s 

mission and/or values; and (3) a 

description of how the organization 

supports or plans to support the SMBP 

Program goals. 

Submission of a letter of interest does 

not guarantee acceptance as a SMBP 

Program partner. 

Authority: 42 U.S.C. 237a and 42 

U.S.C. 300u–2(a). 

Dated: September 14, 2021. 

Dorothy A. Fink, 

Deputy Assistant Secretary for Women’s 

Health. 

[FR Doc. 2021–20456 Filed 9–21–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

52692 Federal Register / Vol. 86, No. 181 / Wednesday, September 22, 2021 / Notices 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–19– 

264: Imaging, Biomarkers and Digital 

Pathomics for the Early Detection of 

Premetastatic Aggressive Cancer. 

Date: October 20, 2021. 

Time: 3:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Eleni Apostolos Liapi. 

Scientific Review Officer. Center for 

Scientific Review. National Institutes of 

Health. 6701 Rockledge Drive. Bethesda, MD 

20817. 301–867–5309. eleni.liapi@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR panel: 

International Research Ethics Education and 

Curriculum Development and Bioethics 

Research Training. 

Date: October 22, 2021. 

Time: 10:00 a.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Seetha Bhagavan, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5194, 

MSC 7846, Bethesda, MD 20892, (301) 237– 

9838, bhagavas@csr.nih.gov. 

Name of Committee: Oncology 2— 

Translational Clinical Integrated Review 

Group; Clinical Oncology Study Section. 

Date: October 25–26, 2021. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health. 

Rockledge II. 6701 Rockledge Drive. 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Malaya Chatterjee, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6192, 

MSC 7804, Bethesda, MD 20892, 301–806– 

2515, chatterm@csr.nih.gov. 

Name of Committee: Bioengineering 

Sciences & Technologies Integrated Review 

Group; Gene and Drug Delivery Systems 

Study Section. 

Date: October 25–26, 2021. 

Time: 9:00 a.m. to 8:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive,Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Jain Krotz, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, 6701 Rockledge Drive, 

Bethesda, MD 20892, (240) 672–8670, 

jain.krotz@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Shared 

Instrumentation: Interdisciplinary Molecular 

Sciences and Technologies (S10). 

Date: October 25–26, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Alexander Gubin, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6046B, 

MSC 7892, Bethesda, MD 20892, 301–408– 

9655, gubina@csr.nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group; 

Clinical Management in General Care 

Settings Study Section. 

Date: October 25–26, 2021. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Lauren Fordyce, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3214, 

Bethesda, MD 20892, (301) 435–6998, 

fordycelm@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Academic Industrial Partnerships for 

Translation of Medical Technologies. 

Date: October 25–26, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Guo Feng Xu, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5122, 

MSC 7854, Bethesda, MD 20892, (301) 237– 

9870, xuguofen@csr.nih.gov. 

Name of Committee: Musculoskeletal, Oral 

and Skin Sciences Integrated Review Group; 

Skeletal Biology Development and Disease 

Study Section. 

Date: October 25–27, 2021. 

Time: 10:00 a.m. to 8:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Aruna K. Behera, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4211, 

MSC 7814, Bethesda, MD 20892, (301) 435– 

6809, beheraak@csr.nih.gov. 

Name of Committee: Cell Biology 

Integrated Review Group; Biology and 

Development of the Eye Study Section. 

Date: October 25–26, 2021. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Thomas Beres, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5148, 

MSC 7840, Bethesda, MD 20892, 301–435– 

1175, berestm@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RM–21–012: 

Pilot Projects Investigating Understudied GProtein Coupled Receptors, Ion Channels, 

and Protein Kinases. 

Date: October 25–26, 2021. 

Time: 10:00 a.m. to 8:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Sergei Ruvinov, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4158, 

MSC 7806, Bethesda, MD 20892, 301–435– 

1180, ruvinser@csr.nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group; 

Pathophysiology of Obesity and Metabolic 

Disease Study Section. 

Date: October 26–27, 2021. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Raul Rojas, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6185, 

Bethesda, MD 20892, (301) 451–6319, rojasr@

mail.nih.gov. 

Name of Committee: Oncology 1—Basic 

Translational Integrated Review Group; 

Molecular Oncogenesis Study Section. 

Date: October 26–27, 2021. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II .6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jian Cao, MD, Scientific 

Review Officer, Center for Scientific Review, 

6701 Rockledge Drive, Bethesda, MD 20892, 

301–827–5902, caojn@csr.nih.gov. 

Name of Committee: Bioengineering 

Sciences & Technologies Integrated Review 

Group; Instrumentation and Systems 

Development Study Section. 

Date: October 26–27, 2021. 

Time: 9:30 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II ,6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Kee Forbes, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5148, 

MSC 7806, Bethesda, MD 20892, 301–272– 

4865, pyonkh2@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Immunology B Integrated Review Group; 

Host Interactions with Bacterial Pathogens 

Study Section. 

Federal Register / Vol. 86, No. 181 / Wednesday, September 22, 2021 / Notices 52693 

Date: October 26–27, 2021. 

Time: 9:45 a.m. to 8:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Fouad A. El-Zaatari, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3186, 

MSC 7808, Bethesda, MD 20892, (301) 435– 

1149, elzaataf@csr.nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group; 

Community Influences on Health Behavior 

Study Section. 

Date: October 26–27, 2021. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Pia Kristiina Peltola, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, 6701 Rockledge Drive, 

Bethesda, MD 20892 (301) 594–9295, 

pia.peltola@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: September 17, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–20519 Filed 9–21–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Aging and 

Technology. 

Date: October 22, 2021. 

Time: 11:00 a.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Video Meeting). 

Contact Person: Kimberly Firth, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Institute on Aging, National 

Institutes of Health, Gateway Building, 7201 

Wisconsin Avenue, Suite 2W200, Bethesda, 

MD 20892, (301) 402–7702 firthkm@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: September 17, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–20520 Filed 9–21–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; Hearing 

and Balance Fellowship Review. 

Date: October 7–8, 2021. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Rockville, MD 20852 

(Virtual Meeting). 

Contact Person: Shiguang Yang, DVM, 

Ph.D., Scientific Review Officer, Division of 

Extramural Activities, NIDCD, NIH, 6001 

Executive Blvd., Room 8349, Bethesda, MD 

20892, 301–496–8683, yangshi@

nidcd.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; Chemical 

Senses Fellowship Review. 

Date: October 12, 2021. 

Time: 11:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Shiguang Yang, DVM, 

Ph.D., Scientific Review Officer, Division of 

Extramural Activities, NIDCD, NIH, 6001 

Executive Blvd., Room 8349, Bethesda, MD 

20892, 301–496–8683, yangshi@

nidcd.nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; Voice, 

Speech and Language Fellowship Review 

Date: October 26, 2021. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Eliane Lazar-Wesley, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, Division of Extramural 

Activities, 6001 Executive Boulevard, Room 

8339, MSC 9670, Bethesda, MD 20892–8401, 

301–496–8683 el6r@nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel Clinical 

Trial Review. 

Date: October 27, 2021. 

Time: 2:00 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Katherine Shim, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, NIH/NIDCD, 6001 

Executive Blvd., Room 8351, Bethesda, MD 

20892, 301–496–8683 katherine.shim@

nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel, NIDCD 

R21/R33 Hearing Health Care Review. 

Date: November 5, 2021. 

Time: 9:00 a.m. to 11:30 a.m., 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Katherine Shim, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, NIH/NIDCD 6001 

Executive Blvd., Room 8351, Bethesda, MD 

20892, 301–496–8683, katherine.shim@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communicative 

Disorders, National Institutes of Health, HHS)